5. Conclusions
muscle mass, NSCLC, CRC, cancer, nutritional deterioration
CANCER, RECRUITMENT, NSCLC
Without specific nutritional intervention, cancer patients often fail to meet the minimum protein intakes recommended by ESPEN guidelines. Adequate protein intake is important to prevent nutritional deterioration and can support muscle mass and function and improve outcomes during treatment. Our results show that the high-protein, high-energy, low-volume ONS was effective at increasing protein intake in line with ESPEN guidelines in a cohort of CRC and NSCLC patients during their first cycle of systemic anti-cancer treatment. Compliance with the ONS was high, suggesting that this could be a nutritional therapy offered early in the patient’s cancer journey that would be feasible to implement into clinical practice. Future research that explores innovative strategies for the recruitment and retention of cancer patients in nutritional studies is warranted.